Clinical Trial

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

Study acronym: SUPLA
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 23, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to determine whether people living with HIV (PLHIV) with suboptimal medical adherence can achieve better viral suppression with long-acting antiretrovirals (LA) compared to all-oral antiretrovirals.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-11.
Status change: Not Yet Recruiting → Recruiting 2024-08-21
Trial Details
NCT Number NCT06507059
Lead Sponsor Chang Gung Memorial Hospital
Collaborators: Taoyuan General Hospital
Conditions HIV-1-infection, Non-Adherence, Medication
Enrollment 40 participants
Start Date 2024-07-19
Primary Completion 2025-07-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-23